Consenso nacional sobre dieta cetogénica

Armeno, Marisa; Caraballo, Roberto; Vaccarezza, María; Alberti, Miguel; Ríos, Viviana Graciela; Galicchio, Santiago; Grandis, Elizabeth S. De; Mestre, Graciela; Escobal, Nidia; Matarrese, Pablo; Viollaz, Rocío; Agostinho, Ariela; Díez, Cecilia; Cresta, Araceli; Cabrera, Analía; Blanco, Virginia; Ferrero, Hilario; Gambarini, Victoria; Sosa, Patricia; Bouquet, Cecilia; Caramuta, Luciana; Guisande, Silvina; Gamboni, Beatriz; Hassan, Amal; Pesce, L; Argumedo, Laura; Dlugoszewski, Corina; Demartini, Martha Graciela; Paníco, Luis

doi:10.33588/rn.5905.2014277

Cited by 20 publications

(12 citation statements)

References 60 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The recommendations of the World Health Organization on the basis of age and weight were used for the remainder of patients [34]. Protein intake was calculated according to daily protein recommendations (generally 1 g per kilo per day in children over 1 year and 1.5 in children under 1 year) [35,36]. Needs of liquids were calculated according to Holliday-Segar method [37].…”

Section: Methodsmentioning

confidence: 99%

Safety and Effectiveness of the Prolonged Treatment of Children with a Ketogenic Diet

et al. 2020

View full text Add to dashboard Cite

Background: The ketogenic diet (KD) is an effective treatment against drug-resistant epilepsy in children. The KD is a diet rich in fats that produces anticonvulsant and neuroprotective effects that reduces seizures and improves the cognitive state. Nevertheless, it can produce side effects that sometimes can be serious. Further, the effect on growth is quite controversial when used for an extended period of time. The aim of this paper was to assess the effectiveness, side effects, and repercussions in the development of children who have been treated with a KD for more than 2 years. Methods: Observational descriptive study of 26 pediatric patients on a KD, with data collection at baseline, at 3, 6, and 12 months, and then once a year. Number of seizures, type of seizures, anti-seizure drugs, anthropometry, side effects, and alterations in laboratory assessment were monitored. Results: In every assessment, about 60%–75% of the patients experienced a reduction in number of seizures of over 90%, and at least 50% experienced side effects, of which digestive issues, alteration in the lipid metabolism, and hypercalciuria were the most common. The KD significantly affected height after 2 years of treatment. Conclusions: The KD is an effective treatment for drug-resistant epilepsy. Its side effects, although common, are very mild; therefore, this constitutes a very safe treatment for children of all ages. More studies are needed to identify and prevent potential causes of growth retardation in children on the KD.

show abstract

Section: Methodsmentioning

confidence: 99%

Safety and Effectiveness of the Prolonged Treatment of Children with a Ketogenic Diet

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The Italian (Veggiotti et al,) [4] and Argentinian (Armeno et al,) [5] consensus were used for KD titration and patient management. All patients underwent classical 4:1 or 3:1 lipid to protein ratio.…”

Section: Methodsmentioning

confidence: 99%

Ketogenic diet use in children with intractable epilepsy secondary to malformations of cortical development: A two- centre experience

Pasca

Caraballo

Giorgis

et al. 2018

Seizure

Self Cite

View full text Add to dashboard Cite

show abstract

“…La indicación de la dieta está a cargo de un neurólogo pediatra, quien determina qué pacientes son candidatos a este tratamiento 21,22 . La decisión de iniciar la dieta o no debe tomarse después de realizar una evaluación integral del paciente y de haber analizado los factores de riesgo y la posibilidad de aparición de efectos adversos al inicio de la dieta 23 .…”

Section: Indicaciones De La Dieta Cetogénicaunclassified

“…Previo al inicio de la DC es necesario descartar situaciones clínicas y sociales en las que la dieta está contraindicada (Tabla 2) 10,23,27 .…”

Section: Contraindicaciones De La Dieta Cetogénicaunclassified

Dieta cetogénica como tratamiento de la epilepsia refractaria durante la infancia: revisión práctica de la literatura

Vásquez-Builes¹,

Jaramillo-Echeverri²,

Montoya-Quinchia³

et al. 2019

RMN

View full text Add to dashboard Cite

La epilepsia es una enfermedad neurológica grave y de evolución crónica que afecta tanto a niños como a adultos. Desde los años veinte, la dieta cetogénica (DC) se ha considerado una opción terapéutica en pacientes con epilepsia refractaria y actualmente se utiliza como primera línea de tratamiento para algunos trastornos metabólicos. La DC puede ser eficaz no solo en epilepsias generalizadas o multifocales sintomáticas, sino también en focales y lesiónales. Su acción antiepiléptica se basa en la teoría de que los cuerpos cetónicos, sintetizados en el hígado a partir de ácidos grasos de cadena larga y media, funcionan como anticonvulsivos directos al cruzar la barrera hematoencefálica. El presente artículo realiza una descripción práctica y detallada de la literatura médica sobre las indicaciones, contraindicaciones, aspectos clínicos, fisiológicos y terapéuticos de la DC, con el objetivo de brindar a la comunidad médica las habilidades necesarias para un cuidado integral de los niños candidatos a DC o que actualmente la utilizan como tratamiento de su epilepsia refractaria.

show abstract

Consenso nacional sobre dieta cetogénica

Cited by 20 publications

References 60 publications

Safety and Effectiveness of the Prolonged Treatment of Children with a Ketogenic Diet

Safety and Effectiveness of the Prolonged Treatment of Children with a Ketogenic Diet

Ketogenic diet use in children with intractable epilepsy secondary to malformations of cortical development: A two- centre experience

Dieta cetogénica como tratamiento de la epilepsia refractaria durante la infancia: revisión práctica de la literatura

Contact Info

Product

Resources

About